Zum Hauptinhalt springen

Hepatitiden

04. Juli 2019 | Hepatitiden

Royalty-free licence for key hepatitis C treatment

Royalty-free licence for key hepatitis C treatment A new royalty-free licence agreement has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company AbbVie for glecaprevir/pibrentasvir (G/P). News of the agreement was announce…

04. Juli 2019 | Hepatitiden

Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs.

Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs. Jost JJ, Tempalski B, Vera T, Akiyama MJ, Mangalonzo AP, Litwin AH. Int J Environ Res Public Health. 2019 Jun 2;16(11). pii: E1958. doi: 10.3390/ijerph16111958…

30. Juni 2019 | Hepatitiden

Hepatitis B: Weniger akute, aber mehr chronische Infektionen in Europa

Hepatitis B: Weniger akute, aber mehr chronische Infektionen in Europa Stockholm. Während die Zahl der akuten Hepatitis B-Infektionen in Europa sinkt, ist die Zahl der Menschen mit chronischen Infektionen seit 2008 gestiegen. Ein Grund dürfte nach…

30. Juni 2019 | Hepatitiden

Enhancing engagement in hepatitis C care among people who inject drugs.

Enhancing engagement in hepatitis C care among people who inject drugs. Marshall, A. D., Madden, A., and Treloar, C. ( 2019) Addiction, doi.org/10.1111/add.14698. https://onlinelibrary.wiley.com/doi/10.1111/add.14698

30. Juni 2019 | Hepatitiden

International Liver Congress (ILC) 2019: Congress Review

International Liver Congress (ILC) 2019: Congress Review The International Liver Congress (ILC) 2019, the 54th annual meeting of the European Association for the Study of the Liver (EASL), was held this year in Vienna, Austria, and was attended by…

24. Juni 2019 | Hepatitiden

A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study.

A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study. Ward KM, Falade-Nwulia O, Moon J, Sutcliffe CG, Brinkley S, Haselhuhn T, Katz S, Herne K, Arteaga L, Me…

24. Juni 2019 | Hepatitiden

Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar.

Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar. Ye M, Chen X, Wang Y, Duo L, Zhang C, Zheng YT. Front Microbiol. 2019 Apr 18;10:814. doi: 10.3389/fmicb.2019.00814. https://www.ncbi.nlm.nih.gov/pmc/articles/P…

Weitere
akutelle Informationen
zu den Themengebieten